Historically, studies of disseminated tumour cells in bone marrow and circulating tumour
cells in peripheral blood have provided crucial insights into cancer biology and the …

The analysis of tumor cells or tumor cell products obtained from blood or other body fluids
(“liquid biopsy”[LB]) provides a broad range of opportunities in the field of oncology. Clinical …

Liquid biopsy (LB) provides a unique minimally invasive tool to follow-up cancer patients
over time, to detect minimal residual disease (MRD), to study metastasis-biology and …

The promise of precision medicine as a model to customize health care to the individual
patient is heavily dependent upon new genetic tools to classify and characterize diseases …

Circulating tumor cells (CTCs) are closely associated with cancer metastasis and
recurrence, so the assessment of CTC viability is crucial for diagnosis, prognosis evaluation …

Circulating tumor cell (CTC) has been a valuable biomarker for the diagnosis of breast
cancer, while folate receptor is a kind of cell surface receptor glycoprotein which is …

Rapid and label-free separation of target cells from biological samples provided unique
opportunity for disease diagnostics and treatment. However, even with advanced …

Simultaneous cell profiling and isolation based on cellular antigen-binding capacity plays an
important role in understanding and treating diseases. However, fluorescence-activated cell …

Methods to separate circulating tumor cells (CTCs) from blood samples were intensively
researched in order to understand the metastatic process and develop corresponding …

Identification and characterization of circulating tumor cells (CTCs) from blood samples of
patients with cancer can help monitor parameters such as disease stage, disease …